Duke-NUS celebrates 20 years of medical innovation with largest ever graduating class

Duke-NUS celebrates 20 years of medical innovation with largest ever graduating class

Duke-NUS Medical School's Class of 2025 graduates 121 medical and doctoral students, including MDs, MD-PhDs, PhDs, and masters' degrees Landmark first batch of Masters in Patient Safety and Healthcare Quality graduates, unique to Southeast Asia...

ImmVira Presented Clinical Results of Oncolytic Product MVR-C5252 Targeting Malignant Glioma via Convection-Enhanced Delivery at 2025 AACR Annual Meeting

ImmVira Presented Clinical Results of Oncolytic Product MVR-C5252 Targeting Malignant Glioma via Convection-Enhanced Delivery at 2025 AACR Annual Meeting

SUZHOU, China, April 28, 2025 /PRNewswire/ -- From April 25 to April 30, 2025, U.S. time, ImmVira presented the Phase I clinical results of its oncolytic Herpes Simplex Virus ("oHSV") product MVR-C5252 targeting malignant glioma through poster...

Patrick Tan appointed as Duke-NUS Dean to lead next era of medical innovation and education

Patrick Tan appointed as Duke-NUS Dean to lead next era of medical innovation and education

SINGAPORE, April 11, 2025 /PRNewswire/ -- Duke-NUS Medical School has appointed Professor Patrick Tan as its next and fourth Dean, effective 1 January 2026, marking a new chapter for the School as it builds on its legacy of medical education,...

Duke and Duke-NUS forge new frontiers in climate health research with S$1million funding

Duke and Duke-NUS forge new frontiers in climate health research with S$1million funding

The two institutions awarded more than S$1 million to accelerate five promising areas of research collaboration Dedicated Research Collaboration Pilot Project grant combines expertise from Singapore and the US for bigger impact First time in the...

menu
menu